abstract |
The present invention relates to compounds having dopamine D3 receptor modulating activity and uses thereof. Specifically, the dopamine receptor D3R can be used as a novel target of post-traumatic stress disorder syndrome (PTSD) for the prevention, treatment/or adjuvant treatment of traumatic PTSD and screening of anti-PTSD drugs. On the other hand, the present invention also relates to the use of a compound having dopamine receptor D3R modulating activity in the preparation of a medicament for the prevention, treatment and/or adjuvant treatment of PTSD. |